How long does a single oral dose of cannabidiol persist in plasma? Findings from three clinical trials.
- Published in:
- Drug Testing & Analysis, 2023, v. 15, n. 3, p. 334, doi. 10.1002/dta.3419
- By:
- Publication type:
- Article
Works matching AU Suraev, Anastasia S
Results: 5
1
2
Orally administered cannabidiol does not produce false‐positive tests for Δ<sup>9</sup>‐tetrahydrocannabinol on the Securetec DrugWipe® 5S or Dräger DrugTest® 5000.
- Published in:
- Drug Testing & Analysis, 2022, v. 14, n. 1, p. 137, doi. 10.1002/dta.3153
- By:
- Publication type:
- Article
3
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial.
- Published in:
- Journal of Psychopharmacology, 2022, v. 36, n. 12, p. 1338, doi. 10.1177/02698811221095356
- By:
- Publication type:
- Article
4
The effect of cannabidiol on simulated car driving performance: A randomised, double‐blind, placebo‐controlled, crossover, dose‐ranging clinical trial protocol.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 5, p. 1, doi. 10.1002/hup.2749
- By:
- Publication type:
- Article
5
Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients.
- Published in:
- Crohn's & Colitis 360, 2020, v. 2, n. 2, p. 1, doi. 10.1093/crocol/otaa045
- By:
- Publication type:
- Article